塞拉万斯生物制药

US · TBPH #3330 按市值排名上市于 2015

17.03 0.00 0.00%

实时 - 追踪5344个代码 - 心跳于7秒前 · 2026-10-15 19:54

✦ 量化股权信号计算方式说明

减持

机构持股总比例下降了0.2个百分点。

机构持股

机构持股比例: 93.30% -0.20pp
机构数量: 218
数据截至: 2026/Q3 较上一报告期

持股变动 vs 资金流向

方向一致

机构在上一报告期减持了股份，同时该股在最近20个交易日的主力资金呈净流出——两者方向一致。

机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。

持股人类型

Hedge Fund53.44%

Mutual Fund35.72%

Individual/Insider6.22%

Public Company2.25%

Private Company1.09%

Government Pension Fund0.59%

Family Office/Trust0.12%

Other0.48%

主要股东截至 2026-07-07

Madison Avenue Partners, LP 17.66% · 9.17M 股

Weiss Asset Management, LLC 14.36% · 7.46M 股

BlackRock 8.79% · 4.56M 股

Newtyn Management, LLC 6.61% · 3.43M 股

Irenic Capital Management LP 5.32% · 2.76M 股

Vanguard Capital Management, LLC 3.94% · 2.04M 股

Rick Winningham 3.33% · 1.73M 股

State Street Global Advisors 2.56% · 1.33M 股

Two Sigma Investments, LP 2.36% · 1.23M 股

D. E. Shaw & Co., L.P. 2.28% · 1.19M 股

条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。

内部人持股

共追踪50份申报 · 17次买入 · 33次卖出

姓名	职务	持股比例
Madison Avenue Partners, LP	--	17.66%
Weiss Asset Management, LLC	--	14.36%
Rick Winningham	Chairperson & CEO	3.33%
Brett Grimaud	Senior Vice President	0.68%
Aziz Sawaf	Senior Vice President	0.65%
Rhonda Farnum	Chief Business Officer and Senior VP of Commercial & Medical Affairs	0.41%
Aine Miller	VP of Regulatory, Quality, Clinical Safety & Pharmacovigilance and Head of Ireland Office	0.37%
Dean Mitchell	Lead Independent Director	0.18%
Laurie Smaldone Alsup	Independent Director	0.14%
Donal O'Connor	Independent Director	0.14%

内部人交易最近的 Form 4 申报记录

日期	姓名	职务	类型	股数	价格
2026-09-14	Rhonda Farnum	Chief Business Officer and Senior VP of Commercial & Medical Affairs	Automatic Disposition	-13,314	$17.03–17.03
2026-08-19	Rick Winningham	Chairperson & CEO	Sale to Issuer	-20,034	$16.95
2026-08-19	Brett Grimaud	Senior Vice President	Sale to Issuer	-7,952	$16.95
2026-08-19	Rhonda Farnum	Chief Business Officer and Senior VP of Commercial & Medical Affairs	Sale to Issuer	-5,667	$16.95
2026-08-19	Aziz Sawaf	Senior Vice President	Sale to Issuer	-8,112	$16.95
2026-08-19	Aine Miller	VP of Regulatory, Quality, Clinical Safety & Pharmacovigilance and Head of Ireland Office	Sale to Issuer	-6,258	$16.95
2026-07-06	Madison Avenue Partners, LP	--	Open Market Disposition	-6,964	$17.04–17.17
2026-06-30	Madison Avenue Partners, LP	--	Open Market Disposition	-336,697	$17.00–17.23
2026-06-18	Aine Miller	VP of Regulatory, Quality, Clinical Safety & Pharmacovigilance and Head of Ireland Office	Other Acquisition	+18,750	--
2026-06-14	Rhonda Farnum	Chief Business Officer and Senior VP of Commercial & Medical Affairs	Automatic Disposition	-13,314	$16.38–16.39
2026-06-11	Deepika Pakianathan	Independent Director	Other Acquisition	+6,009	--
2026-06-11	Deepika Pakianathan	Independent Director	Other Derivative Acquisition	+13,398	$16.64
2026-06-11	Dean Mitchell	Lead Independent Director	Other Acquisition	+6,009	--
2026-06-11	Dean Mitchell	Lead Independent Director	Other Derivative Acquisition	+13,398	$16.64
2026-06-11	Donal O'Connor	Independent Director	Other Acquisition	+6,009	--
2026-06-11	Donal O'Connor	Independent Director	Other Derivative Acquisition	+13,398	$16.64
2026-06-11	Susannah Gray	Independent Director	Other Acquisition	+6,009	--
2026-06-11	Susannah Gray	Independent Director	Other Derivative Acquisition	+13,398	$16.64
2026-06-11	Laurie Smaldone Alsup	Independent Director	Other Acquisition	+6,009	--
2026-06-11	Laurie Smaldone Alsup	Independent Director	Other Derivative Acquisition	+13,398	$16.64

Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。

报价时间 2026-10-15 19:54:59 · 仅供参考，不构成投资建议，也未考虑您的具体情况。